Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common shares (LCTX)
CUSIP: 53566P109
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common shares
- Total 13F shares
- 94,568,251
- Total 13F value
- $85,611,699
- Share change
- -224,925
- Put/Call ratio
- 1.6%
- SEC-reported price per share
- $0.91
- Number of holders
- 112
- Value change
- -$260,148
- Number of buys
- 36
- Number of sells
- 29
- Shares outstanding
- 250,425,788
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q3 2024
Institutions
112
Top holders
10
LCTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Ownership snapshot
Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 17%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
17%
BlackRock Finance, Inc.
3.8%
VANGUARD GROUP INC
3.4%
Defender Capital, LLC.
2%
Logos Global Management LP
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
17%
|
$41,553,756
41,666,255 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
3.8%
|
$9,533,656
9,559,466 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$8,451,087
8,473,967 shares
|
— | 30 Jun 2024 |
| Defender Capital, LLC. |
13F
Company
|
2%
|
$4,959,548
4,972,975 shares
|
— | 30 Jun 2024 |
| Logos Global Management LP |
13F
Company
|
1.9%
|
$4,687,310
4,700,000 shares
|
— | 30 Jun 2024 |
| RAFFLES ASSOCIATES LP |
13F
Company
|
1.7%
|
$4,346,015
4,357,781 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
112
Shares
94,568,251
Rows available
112
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
110
Q3 2024 holders
112
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend